Search Articles and Web Sources

Search Results

In this project

IT Anxiety before AI: 2026 Surveys

https://sudonull.com/it-anxiety-before-ai-2026-surveys

Analysis of Surveys of 277 Specialists: Anxiety Decreased, 63% Expect Changes in 10+ Years. Adaptation Strategies and Common Developer Fears. Study the Data for Your Career.

From other projects

Breakthrough in depression treatment: neurosteroids, psilocybin and Caplyta

https://ymaho.com/breakthrough-in-depression-treatment-neurosteroids-psilocybin-and-caplyta

FDA approved zuranolone, psilocybin passed phase III, and Caplyta doubles the chance of remission. Learn how moving away from the serotonin theory and new NMDA antagonists are changing psychiatry in 2026.

DBS reboots the brain in depression: remyelination mechanism

https://ymaho.com/dbs-reboots-the-brain-in-depression-remyelination-mechanism

Scientists have proven: deep brain stimulation (DBS) physically rebuilds white matter. The axon remyelination mechanism explains the lasting effect in depression. Read details.

How Did the Stock Market Crash of 1929 Trigger the Great Depression?

https://ymaho.com/how-did-the-stock-market-crash-of-1929-trigger-the-great-depression

Learn how did the stock market crash of 1929 trigger the Great Depression through bank failures, Fed policy errors, and trade collapse. Discover the causal chain that changed history.

How Did the Great Depression Reshape Economic Policy?

https://ymaho.com/how-did-the-great-depression-reshape-economic-policy

Discover how did the Great Depression reshape economic policy — from the New Deal to monetary reform. Learn the lasting impact of 1930s policy shifts on today's economy.

Diet for Depression and Alzheimer's: Impact on Biomarkers

https://ymaho.com/diet-for-depression-and-alzheimer-s-impact-on-biomarkers

Mediterranean diet reduces Alzheimer's biomarkers in people with depression by blocking neurodegeneration. Learn how nutrition protects the brain.

Motif Neurotech implant for depression: breakthrough FDA status 2026

https://ymaho.com/motif-neurotech-implant-for-depression-breakthrough-fda-status-2026

Implantable vagus nerve stimulator Motif DOT reduces MADRS by 65% in 8 weeks. Learn how bioelectronics is changing the treatment of resistant depression. Read details.

Zuranolone for postpartum depression: FDA approval 2026

https://ymaho.com/zuranolone-for-postpartum-depression-fda-approval-2026

Analysis of FDA approval of the first oral drug for PPD — zuranolone. Who won and lost, why it was denied for MDD, price, efficacy. Read more.

Recession vs Depression: What's the Real Difference?

https://ymaho.com/recession-vs-depression-what-s-the-real-difference

Learn what is the difference between a recession and a depression. Compare GDP, unemployment, duration, and policy responses to understand economic downturns.

Profit of Russian banks in April decreased by 22% due to ruble strengthening

https://ymaho.com/profit-of-russian-banks-in-april-decreased-by-22-due-to-ruble-strengthening

Analysis of the reasons for the 22% drop in net profit of Russian banks in April 2026: ruble strengthening, currency speculation, hidden losses, and forecast for 30-90 days. Read more.

Deep brain stimulation reshapes neural networks in depression

https://ymaho.com/deep-brain-stimulation-reshapes-neural-networks-in-depression

Nature Neuroscience: DBS physically remodels white matter and induces axonal myelination. A new mechanism for treating resistant depression. Read the details.